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Impact of pharmacist intervention on institutional adherence to 
national hospital inpatient quality measures
•The Centers for Medicare and Medicaid Services (CMS), in conjunction with The
Joint Commission, have created a set of standards collectively known as the
National Hospital Inpatient Quality Measures.
•Institutional performance on these measures has been publically reported with 
the goal of reducing the overall cost of a hospital admission through the 
implementation of national standards of care.
•.
•In October 2012, hospitals with high performance scores will receive higher 
reimbursement from CMS through a process known as value‐based purchasing.
•Studies have shown that hospitals engaged in value‐based purchasing showed
greater improvement in performance on quality measures than hospitals that
simply publically reported data, establishing the benefit of value‐based
purchasing.
•The challenge has become finding methods to ensure high levels of performance
on quality measures.
•At St. Claire Regional, clinical pharmacists are uniquely placed to provide optimal
pharmaceutical care. Pharmacists work as members of the healthcare team by:
•Interacting with various healthcare professionals using the decentralized
pharmacist practice model.
•Attending surgery and ICU rounds
•Assisting in the emergency room
Introduction
Objective
•Based on the current practice model, quality measures were analyzed to
determine which measures a pharmacist would best be able to impact.
•A retrospective review of the indicated quality measures for fiscal year 2011
was conducted to determine baseline performance.
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Prospective Implementation
•An educational presentation regarding the various components of the selected
quality measures.
•The presentation will be made available to pharmacists at St. Claire Regional
Medical Center through the software program, careLearning©.
•There will be a post‐test to ensure that pharmacists have an acceptable
understanding of the information presented.
•Pocket guides will be distributed to pharmacists with information about
appropriate antibiotic selection for surgery and pneumonia patients.
•A reminder checklist will be placed at each workstation to prompt pharmacists
to evaluate post‐operative antibiotic duration, venous thromboembolism
prophylaxis, and pneumococcal vaccination status.
•The percentage scores for performance on these quality measures following the
intervention will be analyzed to determine if there has been change in
performance.
Results
•The measures chosen were:
•Selection of perioperative prophylactic 
antibiotics
•Duration of post‐operative antibiotics
•The purpose of this study is to determine institutional adherence to specific
quality measures following pharmacist intervention.
Methods
Baseline Performance-FY 2011
•Venous thromboembolism prophylaxis
•Antibiotic selection in patients with pneumonia
•Pneumococcal vaccination status. 
Conclusions
•Current average performance on some of the quality measures is not at the desired goal. 
•Pharmacists are uniquely placed to impact adherence to quality measures related to 
medications. 
•Educating all pharmacists on the national inpatient quality measures will ensure that all 
pharmacists are able to suggest changes in therapy for patients whose treatment is not 
meeting the quality measures. 
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CABG, Other 
Cardiac or Vascular 
Colon  Hip/Knee 
Arthroplasty
Hysterectomy 
Cefazolin X  X  X 
Cefazolin + Metronidazole X 
Cefoxitin X  X 
Cefuroxime X  X  X 
Cefuroxime + Metronidazole X 
Clindamycin A  A 
Clindamycin + Aminoglycoside A  A 
Clindamycin + Aztreonam A  A 
Clindamycin + Quinolone A  A 
Ertapenem X 
Metronidazole + Aminoglycoside A  A 
Metronidazole + Quinolone A  A 
Vancomycin  A  A 
